Press "Enter" to skip to content

Tag: diabetes

Common diabetes drug lowers SARS-CoV-2 levels, clinical trial finds

Today, researchers from the University of Minnesota published evidence that the common diabetes drug metformin decreases the amount of SARS-CoV-2 in the body and helps reduce the risk of rebound symptoms if given early in the course of non-severe illness.

The study, published in Clinical Infectious Diseases, suggests metformin may also help prevent long COVID.

The researchers tested metformin against a placebo in 999 adults infected with COVID-19. More than 50% of the study enrollees were vaccinated, and treatment took place when the Omicron variant was the most dominant strain in the United States.

Comments closed

Air Pollution Is Really Dangerous, Even More New Evidence Shows

PM2.5 particles are tiny enough to enter the bloodstream and lodge in the lungs, where they contribute to respiratory problems such as asthma. They also can prompt heart attacks and strokes. And they have been linked to diabetes, obesity and dementia and may exacerbate COVID.

Comments closed

We Interrupt This Mood of Denial to Update COVID’s Threat

Although many Canadians act as though the pandemic has ended, the airborne virus that causes COVID-19 continues to evolve at an amazing pace with devastating consequences for both individuals and the public at large.

Comments closed

Covid may have permanently damaged people’s immunity

Covid infections are putting people at higher risk of diabetes, strokes, heart disease and other long-term illnesses – but experts warn it may be decades before the full impact is known.

Comments closed

Opinion: Study shows ‘long COVID’ likely to cause mass misery if treatments can’t be developed

Given that 103 million Americans and 770 million people worldwide have been diagnosed as having contracted COVID-19, a future of misery could await a stunningly large cross-section of humanity.

Comments closed

Long COVID still worrisome 2 years after infection

Our findings highlight the substantial cumulative burden of health loss due to long COVID and emphasize the ongoing need for health care for those faced with long COVID. It appears that the effects of long COVID for many will not only impact such patients and their quality of life, but potentially will contribute to a decline in life expectancy and also may impact labor participation, economic productivity, and societal well-being.

Comments closed

Long Covid symptoms create a greater burden of disability than heart disease or cancer, new study shows

People who survived Covid-19 early in the pandemic, before there were vaccines, continued to be at higher risk for a slew of health problems for up to two years after they got over their initial infections, compared to others who didn’t test positive, a new study finds, and that was especially true if they were hospitalized.

These health problems include heart problems, blood clots, diabetes, neurologic complications, fatigue and difficulties with mental health and have come to be known collectively as long Covid.

Comments closed

Many long-covid symptoms linger even after two years, new study shows

People who endured even mild cases of covid-19 are at heightened risk two years later for lung problems, fatigue, diabetes and certain other health problems typical of long covid, according to a new study that casts fresh light on the virus’s true toll.

The analysis, published Monday in the journal Nature Medicine, is believed to be the first to document the extent to which an array of aftereffects that patients can develop — as part of the diffuse and sometimes debilitating syndrome known as long covid — linger beyond the initial months or year after they survived a coronavirus infection.

Comments closed

COVID-19 boosts risks of health problems 2 years later, giant study of veterans says

“In the 3 months postinfection, people who’d had COVID-19 had higher rates of death and many health conditions including heart failure, diabetes, Alzheimer’s disease, and depression.”

Comments closed

Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds

Metformin—a cheap, safe, and widely available diabetes drug—could reduce the incidence of long covid if given during the acute phase of covid-19, a new study indicates.

A two week course of metformin given within three days of testing positive for SARS-CoV-2 led to 40% fewer long covid diagnoses over the following 10 months compared with people who had taken placebo, according to a randomised controlled trial.

Leave a comment

Are repeat COVID infections dangerous? What the science says

Nature

April 26, 2023

“People with repeat infections were twice as likely to die and three times as likely to be hospitalized, have heart problems or experience blood clots than were people who were infected only once. In a surprising twist, vaccination status didn’t seem to have an impact — although other studies show vaccines to be protective. Whether these results hold true for the general population is up for debate. The Veterans Affairs cohort was made up mostly of older white men, which is not representative of the wider population.”

Comments closed

Ten COVID Facts Health Officials Dangerously Downplay

Do not listen to powers that be who pretend that getting infected with COVID multiple times is now no big deal. They’re asking you to lower your guard for a nasty virus that can invade the brain, disregulate the immune system and damage the vascular system.

This strategy has led to predictable results — more direct deaths, more excess deaths, more disease and some 1.4 million Canadians reporting some form of long COVID over the last two years.

Comments closed

Diabetes risk rises after COVID, massive study finds

People who get COVID-19 have a greater risk of developing diabetes up to a year later, even after a mild SARS-CoV-2 infection, compared with those who never had the disease, a massive study of almost 200,000 people shows.

Comments closed